We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca Faces Call For Sanctions

Law360 (July 5, 2007, 12:00 AM EDT) -- Drug maker AstraZeneca wants to derail discovery in the case over antipyschotic Seroquel, creating a “discovery filibuster,” according to plaintiffs in the multidistrict litigation.

In their briefs filed Tuesday opposing AstraZeneca's motion to implement case-specific discovery and calling for sanctions, plaintiffs argue the pharmaceutical company's plan is “anything but efficient, cost effective or fair.”

The product liability action, in which plaintiffs allege a link between Seroquel and organ damage, has been mired in disputes over information disclosure for several months.

AstraZeneca had asked a Florida district...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.